Struthers Richard Scott
Insider CIK 1746298 · CRNX President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 195,578 | $62.39 | $12.20M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 313,000 | $48.14 | $15.07M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 240,000 | $41.49 | $9.96M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 172,281 | $59.81 | $10.30M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 228,000 | $41.21 | $9.40M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 259,058 | $69.71 | $18.06M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 244,205 | $64.98 | $15.87M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 287,700 | $65.36 | $18.80M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 1,000 | $85.00 | $85.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 248,043 | $85.00 | $21.08M | 176,663 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 136,805 | $85.00 | $11.63M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 106,000 | $85.00 | $9.01M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 110,000 | $85.00 | $9.35M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 176,663 | $85.00 | $15.02M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 80,000 | $85.00 | $6.80M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 111,100 | $85.00 | $9.44M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 111,100 | $85.00 | $9.44M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 111,100 | $85.00 | $9.44M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 111,100 | $85.00 | $9.44M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 100,000 | $85.00 | $8.50M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 228,000 | $41.21 | $9.40M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 313,000 | $48.14 | $15.07M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 240,000 | $41.49 | $9.96M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 287,700 | $65.36 | $18.80M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 244,205 | $64.98 | $15.87M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 259,058 | $69.71 | $18.06M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 195,578 | $62.39 | $12.20M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 172,281 | $59.81 | $10.30M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 176,663 | $85.00 | $15.02M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 80,000 | $85.00 | $6.80M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 111,100 | $85.00 | $9.44M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 111,100 | $85.00 | $9.44M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 111,100 | $85.00 | $9.44M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 111,100 | $85.00 | $9.44M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 100,000 | $85.00 | $8.50M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 110,000 | $85.00 | $9.35M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 106,000 | $85.00 | $9.01M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 136,805 | $85.00 | $11.63M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 1,000 | $85.00 | $85.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 248,043 | $85.00 | $21.08M | 176,663 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2026-08-07 | 2026-08-11 | 4,995 | — | $0 | 244,205 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2026-08-07 | 2026-08-11 | 6,542 | — | $0 | 259,058 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2026-08-07 | 2026-08-11 | 4,422 | — | $0 | 195,578 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2026-08-07 | 2026-08-11 | 3,969 | — | $0 | 172,281 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2026-08-07 | 2026-08-11 | 3,969 | $25.19 | $100.0K | 408,747 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2026-08-07 | 2026-08-11 | 4,422 | $22.61 | $100.0K | 413,169 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2026-08-07 | 2026-08-11 | 4,995 | $20.02 | $100.0K | 424,706 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2026-08-07 | 2026-08-11 | 6,542 | $15.29 | $100.0K | 419,711 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2026-08-07 | 2026-08-11 | 4,995 | — | $0 | 244,205 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2026-08-07 | 2026-08-11 | 6,542 | — | $0 | 259,058 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2026-08-07 | 2026-08-11 | 4,422 | — | $0 | 195,578 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2026-08-07 | 2026-08-11 | 3,969 | — | $0 | 172,281 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2026-08-07 | 2026-08-11 | 4,995 | $20.02 | $100.0K | 424,706 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2026-08-07 | 2026-08-11 | 6,542 | $15.29 | $100.0K | 419,711 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2026-08-07 | 2026-08-11 | 4,422 | $22.61 | $100.0K | 413,169 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2026-08-07 | 2026-08-11 | 3,969 | $25.19 | $100.0K | 408,747 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2026-05-29 | 2026-06-02 | 111,100 | — | $0 | 515,878 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2026-05-29 | 2026-06-02 | 80,000 | — | $0 | 80,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2026-05-29 | 2026-06-02 | 222,200 | — | $0 | 223,200 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2026-05-29 | 2026-06-02 | 222,200 | — | $0 | 626,978 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2026-05-29 | 2026-06-02 | 80,000 | — | $0 | 136,805 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2026-05-29 | 2026-06-02 | 222,200 | — | $0 | 216,805 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2026-05-29 | 2026-06-02 | 111,100 | — | $0 | 404,778 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2026-05-29 | 2026-06-02 | 111,100 | — | $0 | 111,100 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2026-05-29 | 2026-06-02 | 111,100 | — | $0 | 111,100 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2026-05-29 | 2026-06-02 | 111,100 | — | $0 | 112,100 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2026-05-29 | 2026-06-02 | 111,100 | — | $0 | 1,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2026-05-29 | 2026-06-02 | 111,100 | — | $0 | 111,100 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2026-05-29 | 2026-06-02 | 111,100 | — | $0 | 111,100 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2026-05-29 | 2026-06-02 | 222,200 | — | $0 | 439,005 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2026-03-16 | 2026-03-18 | 8,785 | $37.77 | $331.8K | 404,778 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2026-03-16 | 2026-03-18 | 13,196 | $37.11 | $489.7K | 413,563 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2026-02-23 | 2026-02-25 | 228,000 | — | $0 | 228,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2026-02-23 | 2026-02-25 | 62,000 | — | $0 | 426,759 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2025-12-18 | 2025-12-18 | 28,400 | — | $0 | 259,058 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2025-12-18 | 2025-12-18 | 16,342 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2025-12-18 | 2025-12-18 | 16,342 | $9.28 | $151.7K | 336,359 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2025-12-18 | 2025-12-18 | 28,400 | $15.29 | $434.2K | 364,759 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-09-26 | 2025-09-30 | 4,000 | $45.00 | $180.0K | 106,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2025-05-14 | 2025-05-16 | 90,400 | — | $0 | 661,205 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2025-05-14 | 2025-05-16 | 90,400 | — | $0 | 320,017 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2025-04-02 | 2025-04-04 | 81,270 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2025-04-02 | 2025-04-04 | 81,270 | $1.91 | $155.2K | 410,417 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-03-19 | 2025-03-21 | 16,463 | $34.17 | $562.5K | 330,022 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-03-19 | 2025-03-21 | 875 | $34.83 | $30.5K | 329,147 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2025-02-20 | 2025-02-24 | 313,000 | — | $0 | 313,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2025-02-20 | 2025-02-24 | 89,000 | — | $0 | 346,485 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-12-02 | 2024-12-04 | 10,000 | $57.57 | $575.7K | 100,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-05-08 | 2024-05-10 | 107,448 | — | $0 | 16,342 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-05-08 | 2024-05-10 | 107,448 | $49.40 | $5.31M | 257,485 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-05-08 | 2024-05-10 | 107,448 | $9.28 | $997.1K | 364,933 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2024-04-18 | 2024-04-22 | 350 | — | $0 | 257,485 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-04-15 | 2024-04-17 | 20,000 | — | $0 | 81,270 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-04-15 | 2024-04-17 | 20,000 | $1.91 | $38.2K | 257,835 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-04-04 | 2024-04-08 | 40,951 | — | $0 | 123,790 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-04-04 | 2024-04-08 | 40,951 | $9.28 | $380.0K | 278,786 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-04-04 | 2024-04-08 | 40,951 | $49.17 | $2.01M | 237,835 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | F Tax w/h | 2024-03-18 | 2024-03-20 | 12,687 | $38.14 | $483.9K | 237,835 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2024-03-04 | 2024-03-06 | 240,000 | — | $0 | 240,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2024-03-04 | 2024-03-06 | 65,000 | — | $0 | 250,522 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2024-02-12 | 2024-02-14 | 20,000 | — | $0 | 110,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2024-02-12 | 2024-02-14 | 60,000 | — | $0 | 570,805 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2024-02-12 | 2024-02-14 | 20,000 | — | $0 | 110,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2024-02-12 | 2024-02-14 | 20,000 | — | $0 | 110,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2023-11-09 | 2023-11-13 | 50,000 | — | $0 | 101,270 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2023-11-09 | 2023-11-13 | 50,000 | $1.91 | $95.5K | 185,522 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2023-11-03 | 2023-11-06 | 199,082 | — | $0 | 164,741 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-11-03 | 2023-11-06 | 199,082 | $30.56 | $6.08M | 135,522 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2023-11-03 | 2023-11-06 | 199,082 | $9.28 | $1.85M | 334,604 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2023-11-02 | 2023-11-06 | 918 | — | $0 | 363,823 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2023-11-02 | 2023-11-06 | 918 | $9.28 | $8.5K | 136,440 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-11-02 | 2023-11-06 | 918 | $29.95 | $27.5K | 135,522 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2023-08-14 | 2023-08-16 | 10,000 | — | $0 | 151,270 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2023-08-14 | 2023-08-16 | 10,000 | $1.91 | $19.1K | 135,522 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-07-13 | 2023-07-13 | 14,157 | $20.35 | $288.1K | 630,805 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-07-12 | 2023-07-13 | 11,459 | $20.17 | $231.1K | 644,962 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-07-11 | 2023-07-13 | 24,384 | $20.14 | $491.1K | 656,421 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-06-16 | 2023-06-21 | 50,000 | $20.81 | $1.04M | 680,805 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | F Tax w/h | 2023-03-16 | 2023-03-17 | 4,628 | $17.12 | $79.2K | 125,522 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2023-03-01 | 2023-03-03 | 287,700 | — | $0 | 287,700 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2023-03-01 | 2023-03-03 | 61,650 | — | $0 | 130,150 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2022-10-12 | 2022-10-14 | 11,100 | — | $0 | 161,270 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2022-10-12 | 2022-10-14 | 11,100 | $1.91 | $21.2K | 68,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-04-13 | 2022-04-15 | 69,176 | $27.53 | $1.90M | 730,805 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-04-13 | 2022-04-15 | 44,793 | $26.52 | $1.19M | 799,981 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-04-13 | 2022-04-15 | 24,674 | $25.42 | $627.2K | 844,774 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-04-05 | 2022-04-07 | 21,357 | $25.34 | $541.2K | 869,448 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2022-02-28 | 2022-03-02 | 249,200 | — | $0 | 249,200 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2022-02-28 | 2022-03-02 | 53,400 | — | $0 | 57,400 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2021-09-07 | 2021-09-09 | 10,000 | $25.00 | $250.0K | 90,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2021-09-07 | 2021-09-09 | 10,000 | $25.00 | $250.0K | 90,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2021-09-07 | 2021-09-09 | 10,000 | $25.00 | $250.0K | 90,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2021-02-26 | 2021-03-02 | 294,000 | — | $0 | 294,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2020-12-03 | 2020-12-04 | 4,000 | $13.10 | $52.4K | 4,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2020-12-02 | 2020-12-04 | 1,000 | $12.60 | $12.6K | 1,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-07-16 | 2020-07-17 | 17,500 | $14.46 | $253.1K | 890,805 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-07-15 | 2020-07-17 | 17,500 | $15.30 | $267.8K | 908,305 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2020-02-24 | 2020-02-26 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2019-08-05 | 2019-08-07 | 10,000 | — | $0 | 172,370 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2019-08-05 | 2019-08-07 | 10,000 | $1.91 | $19.1K | 1,225,805 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2019-05-08 | 2019-08-07 | 1,215,805 | — | $0 | 1,215,805 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | G Gift | 2019-05-08 | 2019-08-07 | 1,215,805 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2019-03-08 | 2019-03-12 | 176,250 | — | $0 | 176,250 | SEC↗ |